







1. Lippman ME. Breast Cancer. In: Kasper DL, Hauser SL, Jameson JL, 
Fauci A, Longo DL, Loscalzo J, eds. Harrison’s Principles of Internal 
Medicine. 19th ed. McGraw-Hill Education; 2015:523-532. 
2. Miller, K. Estrogen and DNA Damage: The Silent Source of Breast Cancer. 
J Natl Cancer Inst. 2003;95(2):100-102. doi:10.1093/jnci/95.2.100. 
3. Pusat Data dan Informasi Kementerian Kesehatan RI. Stop Kanker. Jakarta; 
2015. 
4. Al-Amri AM. Prevention of Breast Cancer. J Family Community Med. 
2005;12(2):71-74 
5. Beenken SW, Bland KI, Copeland EM. The Breast. in: Brunicardi FC, 
Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE, eds. 
Schwartz’s Principles of Surgery. 8th ed. McGraw-Hill’s Access Medicine;  
2007. 
6. Meiyanto E, Susilowati S, Tasminatun S, Murwanti R, Sugiyanto. Efek 
kemopreventif ekstrak etanolik Gynura procumbens ( Lour ), Merr pada 
karsinogenesis kanker payudara tikus. Maj Farm Indones. 2007;18(3):154-
161. 
7. Teoh WY, Sim KS, Moses Richardson JS, Abdul Wahab N, Hoe SZ. 
Antioxidant Capacity, Cytotoxicity, and Acute Oral Toxicity of Gynura 
bicolor. Evid Based Complement Alternat Med. 2013;2013:1-10. 
8. Poeaim S, Vanijajiva O. Morphological Identification and In Vitro 
Cytotoxic Evaluation of Crude Extracts from Jak-Na-Rai(Gynura 
divaricata (L.) DC.). 16th Asian Agricultural Conference; 2010 Aug 25-
27; Bangkok. 
9. Chunpeng W, Yanying Y, Shouran Z, Wei L, Shuge T, Shuwen C. 
Antioxidant activity and free radical-scavenging capacity of Gynura 






10. Abdel-Salam OM, Youness ER, Hafez HF. The antioxidant status of the 
plasma in patients with breast cancer undergoing chemotherapy. Open J 
Mol Integr Physiol. 2011;1:29-35. doi:10.4236/ojmip.2011.13005. 
11. Sahu A, Varma M, Kachhawa K.  A Prognostic Study of MDA, SOD and 
Catalase in Breast Cancer Patients. International Journal of Science and 
Research. 2015;4(5):157-159. 
12. Abdulkareem IH. Aetio-pathogenesis of Breast Cancer. Niger Med J. 
2013;54(6):371-375. doi:10.4103/0300-1652.126284. 
13. Kementerian Kesehatan RI. Hilangkan Mitos Tentang Kanker. Jakarta; 
2014. 
14. Chapa J, Bourgo RJ, Greene GL, Kulkarni S, An G. Examining the 
Pathogenesis of Breast Cancer Using a Novel Agent-Based Modelof 
Mammary Ductal Epithelium Dynamics. PloS One. 2013;8(5):1-18. doi: 
10.1371/journal.pone.0064091. 
15. Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a 
common pathway of genomic protection. Nat Rev Cancer. 2011;12(1):68-
78. doi:10.1038/nrc3181. 
16. Rios-Arrabal S, Artacho-Cordon F, Leon J. Involvement of free radicals in 
breast cancer. SpringerPlus. 2013;2:404. doi:10.1186/2193-1801-2-404. 
17. Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson AN 
et al. Diagnostic Concordance Among Pathologist Interpreting Breast 
Biopsy Specimens. JAMA. 2015;313(11):1122-1132. 
doi:10.1001/jama.2015.1405. 
18. Kataja V, Castiglione M. Primary breast cancer: ESMO clinical 
recommendations for diagnosis, treatment and follow-up. Ann Oncol. 
2009;20(4):10-14. doi:10.1093/annonc/mdp114. 
19. Wang H, Singh AP, St.Luce SA, Go AR. Breast Cancer Treatment 
Practices in Elderly Women in a Community Hospital. Int J Breast 
Cancer. 2011;1-7. doi:10.4061/2011/467906. 
20. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of 
chemotherapy and hormonal therapy for early breast cancer on recurrence 






21. Monteiro LS, Bastos KX, Barbosa-Filho JM, Athayde-Filho F, Diniz MF, 
Sobral MV. Medicinal Plants and Other Living Organisms with Antitumor 
Potential against Lung Cancer. J Evid Based Complementary Altern Med. 
2014:1-15. doi:10.1155/2014/604152. 
22. Wheat J, Currie G. Herbal medicine for cancer patients: An evidence 
based review. The Internet Journal of Alternative Medicine. 2007;5(2):1-
11. 
23. Kanadaswami C, Lee LT, Lee MT, Hwang JJ, Ke FC, Huang YT et al. 
The Antitumor Activities of Flavonoids. In Vivo. 2005;19(5):895-909. 
24. Spilioti E, Jaakkola M, Tolonen T, Lipponen M, Virtanen V, Chinou et al. 
Phenolic acid composition, antiatherogenic and anticancer potential of 
honeys derived from various regions in Greece. PloS One. 
2014;9(4)doi:10.1371/journal.pone.0094860. 
25. Indap MA, Radhika S, Motiwale L, Rao KV.  Anticancer activity of 
phenolic antioxidants against breast cancer cells and a spontaneous 
mammary tumor. Indian J Pharm Sci. 2006;68(4):470-474. doi: 
10.4103/0250-474X.27820. 
26. Ahmad R, Tripathi AK, Tripathi P, Singh S, Singh R, Singh RK. 
Malondialdehyde and Protein Carbonyl as Biomarkers for Oxidative Stress 
and Disease Progression in Patients with Chronic Myeloid Leukemia. In 
Vivo. 2008;22:525-528. 
27. Didziapetriene J, Smailyte G, Bublevic J, Kazbariene B, Kasiulevicius V, 
Stukas R. Relationship of MDA plasma concentrations to long-term 
survival of breast cancer patients. Tumori. 2014;100(3):333-337. doi: 
10.1700/1578.17220. 
28. Fang SC, Hsu CL, Lin HT, Yen GC. Anticancer effects of flavonoid 
derivatives isolated from Millettia reticulata Benth in SK-Hep-1 human 
hepatocellular carcinoma cells. J Agric Food Chem. 2010;58(2):814-820. 
doi: 10.1021/jf903216r. 
29. Chahar MK, Sharma N, Dobhal MP, Joshi YC. Flavonoids: A versatile 







30. Mandal SM, Chakraborty D, Dey S. Phenolic acids act as signaling 
molecules in plant-microbe symbioses. Plant Signal Behav. 2010; 5(4): 
359–368. PMCID: PMC2958585. 
31. Gomes CA, da Cruz TG, Andrade JL, Milhazes N, Borges F, Marques MP. 
Anticancer Activity of Phenolic Acids of Natural or Synthetic Origin: A 
Structure-Activity Study. J Med Chem. 2003;46:5395-5401. 
doi:10.1021/ijm030956v. 
32. Fiuza SM, Gomes C, Teixeira LJ, Girao da Cruz MT, Cordeiro MN, 
Milhazes N et al. Phenolic acid derivatives with potential anticancer 
properties––a structure–activity relationship study. Part 1: Methyl, propyl 
and octyl esters of caffeic and gallic acids. Bioorg Med Chem. 
2004;12(13):3581-3589. doi:10.1016/j.bmc.2004.04.026 
33. Seow LJ, Beh HK, Umar MI, Sadikun A, Asmawi MZ. Anti-inflamatory 
and antioxidant activities of methanol extract of Gynura segetum leaf. Int 
immunopharmacol. 2014;23(1):186-191. doi: 
10.1016/j.intmp.2014.08.020. 
34. Chunpeng W, Yanying Y, Shouran Z, Shuge T, Shuwen C. Isolation and 
identification of phenolic compounds from Gynura divaricata leaves. 
Pharmacogn Mag. 2011;7(26):101-108. doi:  10.4103/0973-1296.80666. 
35. Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ et al. Transgenic 
Mice Overexpressing Glutathione Peroxidase 4 Are Protected against 
Oxidative-Stress Induced Apoptosis. J Biol Chem. 2004;279(53):55137-
55146.  
36. Scimeca MS, Lisk DJ, Prolla T, Lei XG. Effects of gpx4 haploid 
insufficiency on GPx4 activity, selenium concentration, and paraquat-
induced protein oxidation in murine tissues. Exp biol med. 2005; 
230(10):709-714. 
37. Yan LJ, Ran Q, Rao L, Van Remmen H, Shibatani L, Belter JG et al. The 
selenoprotein GPX4 is essential for mouse development and protects from 






38. Akbulut H, Akbulut KG, Icli F, Buyukcelik A. Daily variations of plasma 
malondialdehyde levels in patients with early breast cancer. Cancer Detect 
Prev. 2003;27(2):122-126. 
39. Gonenc AM, Erten D, Aslan S, Akinci M, Simsek B, Torun M. Lipid 
peroxidation and antioxidant status in blood and tissue of malignant breast 
tumor and benign breast disease. Cell Biol Int. 2006;30(4):376-380. 
40. Barrera G. Oxidative stress and lipid peroxidation products in cancer 
progression and therapy. ISRN Oncol. 2012;137289. 
41. Xu BQ, Yang P, Zhang QY. Hypoglycemic activities of lyophilized 
powder of Gynura divaricata by improving antioxidant potential and 
insulin signaling in type 2 diabetic mice. Food Nutr Res. 2015;59:29652. 
42. Deng XH, Song HY, Zhou YF, Yuan GY, Zheng FJ. Effects of quercetin 
on the proliferation of breast cancer cells and expression of survivin in 
vitro. Exp Ther Med. 2013;6(5):1155-1158. 
43. Kim SH, Choi KC. Anti-cancer effect and underlying mechanism(s) of 
kaempferol, an phytoestrogen, on the regulation of apoptosis in diverse 
cancer cell models. Toxicol Res. 2013;29(4):229-234. 
44. Seow LJ, Beh HK, Majid AMSA, Murugaiyah V, Ismail N, Asmawi MZ. 
Anti-angiogenic activity of Gynura segetum leaf extracts and its fractions. 
Journal of ethnopharmacology. 2010;134(2011):221-227. 
45. Rice C, Huang LE. From antiangiogenesis to hypoxia: current research and 
future directions. Cancer Manag Res. 2011;3:916. 
46. Brown Ns, Bicknell R. Hypoxia and oxidative stress in breast cancer: 
Oxidative stress: its effects on the growth, metastatic potential and 




































Lampiran 4. Data uji statistik menggunakan SPSS 21.0 
Descriptives 
 






Mean 2,67100 ,184473 








5% Trimmed Mean 2,68511  
Median 2,79500  
Variance ,170  
Std. Deviation ,412494  
Minimum 2,002  
Maximum 3,086  
Range 1,084  
Interquartile Range ,678  
Skewness -1,296 ,913 
Kurtosis 2,011 2,000 
Kontrol Positif 
Mean 4,08780 ,813077 








5% Trimmed Mean 4,08406  
Median 3,44000  





Minimum 2,196  
Maximum 6,047  
Range 3,851  
Interquartile Range 3,541  
Skewness ,351 ,913 
Kurtosis -2,969 2,000 
Perlakuan 
Mean 3,23340 ,511587 












5% Trimmed Mean 3,25089  
Median 3,31000  





Minimum 1,735  
Maximum 4,417  
Range 2,682  
Interquartile Range 2,223  
Skewness -,319 ,913 








 Statistic df Sig. Statistic df Sig. 
kadar mda 
Kontrol Negatif ,232 5 ,200
*
 ,908 5 ,456 
Kontrol Positif ,253 5 ,200
*
 ,843 5 ,174 
Perlakuan ,209 5 ,200
*
 ,931 5 ,606 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
Test of Homogeneity of Variances 
kadar mda   
Levene Statistic df1 df2 Sig. 










Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic Df Sig. Statistic Df Sig. 
logmdakn ,263 5 ,200
*
 ,870 5 ,266 
logmdakp ,245 5 ,200
*
 ,886 5 ,336 
logmdap ,198 5 ,200
*
 ,918 5 ,519 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
Test of Homogeneity of Variances 
log_mda   
Levene Statistic df1 df2 Sig. 




log_mda   
 Sum of Squares df Mean Square F Sig. 
Between Groups ,060 2 ,030 1,217 ,330 
Within Groups ,294 12 ,025   















Lampiran 6. Prosedur Kerja Pemeriksaan MDA 
1. Alat:  
-spektrofotometer 
-vortex 
-tabung reaksi 10 ml 
-mikropipet 10 mikroliter – 100 mikroliter 
-mikropipiet 100 mikroliter – 1000 mikroliter 
-beckerglass 100 ml 




-rak tabung logam 
2. Bahan: 
-TBA (thiobarbituric acid) 








-40,5 ml (asam asetat yg dibuffer sampai pH 3,5 dengan NAOH 1N) 
-13,2 ml SDS 8,2% 
-40,5 ml (TBA 0,8% dalam aquabidest) 
Campurkan ketiganya dan tambah dengan aquabidest hingga 100 ml 
Reagen ekstrak butanol: 
n-butanol: aquabidest:pyridine (15:3:1) 
Standard MDA: 
1.1.3.3-tetramethoxypropane 1 M (indukan) 
Encerkan 1000x dengan aquabidest  





4. Cara kerja 
 Blanko Standar Sampel 
Aquabidest 400 µl   
Standard  400 µl  
Serum   400 µl 
Reagen TBA 1600 µl 1600 µl 1600 µl 
-vortex & tutup tabung dengan kelereng, inkubasi pada suhu 90   selama 80 
menit. 
-dinginkan dg air es selama 10 menit. 
-tambahkan tiap tabung dengan 1600 µl reagen ekstrak butanol & vortex. 
-sentrifuge 3500 rpm selama 15 menit. 
-supernatan diambil 750 µl & dibaca pada panjang gelombang 510, 532, 560 
nm 
Kadar MDA (mmol/L) = (Actual A532 sampel – Actual A532 blank)/(Actual 












Lampiran 8. Dokumentasi penelitian 
 
Tikus dengan benjolan sebagai tanda keganasan
 
Darah tikus sebelum disentrifuge 
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